NL-OMON35301已完成不适用
A Randomised, Placebo Controlled, Ascending, Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278 - GSK356278 MAD study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Healthy male and female volunteers
- •- Age between 18 - 65 years
- •- BMI between 19.0 - 30.0 kg/m2
- •- Only non-smokers
排除标准
- •Suffering from: Hepatitis B or C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 90 days from the start of the study of in case of donating more than 1.5 liters of blood (for men) or more than 1.0 liters of blood (for women) in the 10 months prior the start of this study.
研究者
相似试验
已完成
1 期
An Ascending-dose, Randomized, Placebo-controlled, Parallel, Double-blind, Single-dose, First-in-Human Study to Evaluate the Safety and Pharmacokinetics of RECCE®327 in Healthy Male SubjectsACTRN12621001313820Recce Pharmaceuticals, Ltd.75
已完成
不适用
A Randomized, Placebo-controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile of REC-4881 in Healthy VolunteersColon cancerNL-OMON51761Recursion Pharmaceuticals, Inc.24
招募中
1 期
A Clinical trial of a drug (ADV-1002401) to evaluate safety, tolerability, in adult male Type-II diabetic subjectsCTRI/2011/04/001661Advinus Therapeutics Ltd60
进行中（未招募）
1 期
A study to look at different types and doses of medications called inhaled corticosteroids (ICS), and compare how they effect the lungs. ICS drugs are a common treatment for asthma and have an anti-inflammatory effect in the airways of the lungs.AsthmaEUCTR2016-003002-14-DEGlaxoSmithKline Research & Development Limited48
进行中（未招募）
1 期
A study to look at different types and doses of medications called inhaled corticosteroids (ICS), and compare how they effect the lungs. ICS drugs are a common treatment for asthma and have an anti-inflammatory effect in the airways of the lungs.AsthmaMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2016-003002-14-GBGlaxoSmithKline Research & Development Limited56